Department for Dermatology, Venerology and Allergology, University School of Medicine, Essen, Germany.
ICW (Initiative Chronische Wunden) e.V., Quedlinburg, Germany.
J Wound Care. 2020 Dec 2;29(12):720-726. doi: 10.12968/jowc.2020.29.12.720.
Local wound infections are a major challenge for patients and health professionals. Various diagnostic and therapeutic options are available. However, a generally accepted standard is still lacking in Europe. The aim was to develop an easy-to-use clinical score for the early detection of local wound infections, as a basis for decision-making on antiseptic therapy or decolonisation.
An interdisciplinary and interprofessional panel of experts from seven European countries was brought together to discuss the various aspects of diagnosing local wound infections.
The result was the adoption of the Therapeutic Index for Local Infections (TILI) score, developed in Germany by Initiative Chronische Wunden e.V., specifically for health professionals not specialised in wound care. Available in six European languages, the TILI score could also be adapted for different European countries, depending on their specific national healthcare requirements. The six clinical criteria for local wound infection are erythema to surrounding skin; heat; oedema, induration or swelling; spontaneous pain or pressure pain; stalled wound healing; and increase and/or change in colour or smell of exudate. Meeting all criteria indicates that antiseptic wound therapy could be started. Regardless of these unspecific clinical signs, there are also health conditions for the clinical situation which are a direct indication for antimicrobial wound therapy. These include the presence of wound pathogens, such as meticillin-resistant , septic surgical wound or the presence of free pus.
The development of the new internationally adapted TILI score, which could also be used by any caregiver in daily practice to diagnose local infections in acute and hard-to-heal wounds, is the result of expert consensus. However, the score system has to be validated through a clinical evaluation. This is to be performed in expert centres throughout Europe.
局部伤口感染是患者和医务人员面临的主要挑战。目前已有多种诊断和治疗方法可供选择,但在欧洲仍缺乏被广泛认可的标准。本研究旨在制定一种易于使用的临床评分系统,以便早期发现局部伤口感染,为选择抗菌治疗或去定植提供依据。
来自七个欧洲国家的跨学科和跨专业专家小组对诊断局部伤口感染的各个方面进行了讨论。
采用了德国慢性伤口倡议组织(Initiative Chronische Wunden e.V.)开发的局部感染治疗指数(Therapeutic Index for Local Infections, TILI)评分。该评分专为非专业伤口护理人员设计,有六种欧洲语言版本,可根据不同欧洲国家的具体国家医疗保健需求进行调整。局部伤口感染的 6 项临床标准为:周围皮肤红斑;发热;水肿、硬结或肿胀;自发性疼痛或压痛;伤口愈合停滞;渗出物颜色或气味增加或改变。满足所有标准表明可以开始进行抗菌伤口治疗。无论是否存在这些非特异性临床症状,还有一些临床情况也需要进行抗菌治疗,如伤口存在病原体(如耐甲氧西林金黄色葡萄球菌)、感染性手术伤口或有脓性分泌物。
新的国际适用 TILI 评分的制定,是专家共识的结果,任何护理人员都可以在日常实践中使用该评分来诊断急性和难愈伤口的局部感染。但是,评分系统需要通过临床评估进行验证。这将在欧洲各地的专家中心进行。